B+
Bull case
25%
Probability
Target price
$24.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
ANIK
Anika TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Q2 showed broad operating improvement: record commercial revenue, stronger international growth, gross-margin expansion, and the highest adjusted EBITDA since 2020. Raised FY2026 guidance supports a cautiously improved operating thesis.
Posture
Mixed
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-10-29.
What can break
2027 guidance reset and exclusion of Hyalofast revenue
Momentum
91
Value
47
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $21.00 · Bull $24.00 · Bear $16.00Analysis 2026-08-03; returns require an exact persisted reference.
Earnings
2026-10-29
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $23.00
Why
Momentum91 · Δ7d +15.7
Value47 · Δ7d -0.2
Sentiment51 · Δ7d -7.5
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-10-29.
- • Sentiment remains the lead driver in the composite, 7D delta -7.5.
Contradictions & invalidation
- • 2027 guidance reset and exclusion of Hyalofast revenue
- • Cingal bioequivalence, CMC, and NDA timing risk
- • Second-half results may moderate because of OEM order timing and pricing pressure.
Catalyst clock
2026-10-29
Q2 2026 operating improvement and raised FY2026 outlook
Lead driver: Sentiment · See AI snapshot
Momentum
91
8% active weight
Current posture
7d trendImproving
Δ7d
+15.7
Δ21d
+7.2
Value
47
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.8
Sentiment
51
45% active weight
Current posture
7d trendSoftening
Δ7d
-7.5
Δ21d
-20.7
Why this grade
Composite grade C. Momentum 91.2 / Value 47.4 / Sentiment 50.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-03. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$21.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$16.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$286.66M
Beta
0.43
Shares Out
13.38M
P/E (TTM)
10.1
P/S (TTM)
1.66
P/FCF (TTM)
210.75
Rev YoY
+15.6%
EPS YoY
-187.3%
Gross Margin
+62.2%
Op Margin
-4.2%
Net Debt
-$31.23M
Current Ratio
4.48
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data